Related Experiment Video
Updated: Jun 30, 2026
05:58
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Guidelines for the management of patients with chronic stable angina: treatment
S D Fihn1, S V Williams, J Daley
1NW Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System 152, 1660 South Columbian Way, Seattle, WA 98108, USA.
Annals of Internal Medicine
|October 17, 2001
Summary
Beta-blockers are the first-line treatment for chronic stable angina, with calcium antagonists and nitrates as alternatives. Revascularization procedures like coronary artery bypass grafting (CABG) may improve survival in select patients.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Chronic stable angina management aims to reduce mortality and improve quality of life.
- Initial therapy typically involves beta-blockers due to their efficacy and safety profile.
Framework:
- Beta-blockers are recommended first-line therapy for angina.
- Calcium antagonists and long-acting nitrates serve as alternatives for patients with contraindications or persistent symptoms.
- Aspirin therapy (75-325 mg daily) is crucial for all angina patients unless contraindicated.
Implementation:
- Risk factor modification, including smoking cessation, lipid management, diabetes control, and hypertension treatment, is essential.
- Coronary revascularization (CABG or percutaneous transluminal coronary angioplasty) is considered for symptom control and, in specific cases, survival benefits.
- CABG offers survival advantages for patients with left-main or multi-vessel disease.
Implications:
- While medical therapy and revascularization yield similar long-term angina relief, CABG improves survival in high-risk groups.
- Percutaneous transluminal coronary angioplasty may offer better short-term angina control in low-risk patients but with higher recurrence rates.
- Individualized long-term follow-up and patient education are vital for sustained management and prognosis assessment.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
01:29Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...